These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3017089)

  • 1. Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood.
    Barrett JE; Dawson G; Heller J; Bairstow C; Fico R; Webber JS; Gutierrez R; Decker RH
    Am J Clin Pathol; 1986 Aug; 86(2):180-5. PubMed ID: 3017089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.
    Ward JW; Grindon AJ; Feorino PM; Schable C; Parvin M; Allen JR
    JAMA; 1986 Jul; 256(3):357-61. PubMed ID: 3014173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods.
    Gallo D; Diggs JL; Shell GR; Dailey PJ; Hoffman MN; Riggs JL
    J Clin Microbiol; 1986 Jun; 23(6):1049-51. PubMed ID: 3011854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay.
    Biberfeld G; Bredberg-Råden U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
    Scand J Immunol; 1985 Mar; 21(3):289-92. PubMed ID: 2986278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HTLV-III testing of blood donors: reproducibility and confirmability of commercial test kits.
    Holland PV; Richards CA; Teghtmeyer JR; Douville CM; Carlson JR; Hinrichs SH; Pedersen NC
    Transfusion; 1985; 25(4):395-7. PubMed ID: 2992129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test.
    Jungkind DL; DiRenzo SA; Young SJ
    J Clin Microbiol; 1986 Feb; 23(2):381-2. PubMed ID: 3009536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
    Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R
    Blood; 1985 Sep; 66(3):742-4. PubMed ID: 2992644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-I-specific antibody in AIDS patients and others at risk.
    Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH
    Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three commercial screening tests for AIDS virus antibodies.
    Carlson JR; Hinrichs SH; Yee J; Gardner MB; Pedersen NC
    Am J Clin Pathol; 1986 Sep; 86(3):357-9. PubMed ID: 3019124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
    Abb J
    Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
    Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG
    J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
    Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.